Genetics of Pancreatic Neuroendocrine Tumors

被引：5
|
作者：
Mohindroo, Chirayu [1 ,2 ]
McAllister, Florencia [1 ,3 ,4 ,5 ]
De Jesus-Acosta, Ana [6 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, 1515 Holcombe,Unit 1360, Houston, TX 77030 USA
[2] Sinai Hosp Baltimore, Dept Internal Med, 2435 W Belvedere Ave,Ste 56, Baltimore, MD 21215 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX USA
[5] Univ Texas MD Anderson Canc Ctr, Clin Canc Genet Program, Houston, TX USA
[6] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Dept Oncol, Sch Med, CRB1,1650 Orleans St,CRB1 Rm 409, Baltimore, MD 21287 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2022年 / 36卷 / 05期
关键词：
Pancreatic neuroendocrine tumors; Germline mutations; Somatic mutations; Precision medicine; Molecular therapies; Targeted therapies; VON-HIPPEL-LINDAU; ENDOCRINE NEOPLASIA TYPE-1; OCTREOTIDE LAR; EVEROLIMUS; EFFICACY; THERAPY; MEN1; EXPRESSION; MANAGEMENT; MUTATION;
D O I：
10.1016/j.hoc.2022.07.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Genetic testing is becoming increasingly important in the management of pNETs. Although our knowledge in the field is still evolving, advances in genetic sequencing have increased our understanding of the complex genetic mechanisms underlying pNET formation. Clinicians should consider incorporating genomic testing into treatment paradigms and involving genetic counsellors to help patients and family members with decisions regarding genetic testing, interpretation, and follow-up.
引用
收藏
页码：1033 / 1051
页数：19
相关论文
共 50 条
  • [31] Sunitinib in pancreatic neuroendocrine tumors
    Raymond, Eric
    Hammel, Pascal
    Dreyer, Chantal
    Maatescu, Christian
    Hentic, Olivia
    Ruszniewski, Philippe
    Faivre, Sandrine
    TARGETED ONCOLOGY, 2012, 7 (02) : 117 - 125
  • [32] RADIOTHERAPY FOR PANCREATIC NEUROENDOCRINE TUMORS
    Contessa, Joseph N.
    Griffith, Kent A.
    Wolff, Elizabeth
    Ensminger, William
    Zalupski, Mark
    Lawrence, Theodore S.
    Ben-Josef, Edgar
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (04): : 1196 - 1200
  • [33] Pancreatic Neuroendocrine Tumors: an Update
    Alessandro Paniccia
    Barish H. Edil
    Richard D. Schulick
    Indian Journal of Surgery, 2015, 77 : 395 - 402
  • [34] Pancreatic and Ileal Neuroendocrine Tumors
    Asa, Sylvia L.
    Mohamed, Amr
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2024, 48 (11) : 1417 - 1424
  • [35] Pancreatic neuroendocrine tumors: a review
    Young, Kate
    Iyer, Ridhima
    Morganstein, Daniel
    Chau, Ian
    Cunningham, David
    Starling, Naureen
    FUTURE ONCOLOGY, 2015, 11 (05) : 853 - 864
  • [36] Hope for pancreatic neuroendocrine tumors
    Rebecca Kirk
    Nature Reviews Clinical Oncology, 2011, 8 (4) : 191 - 191
  • [37] Cystic Pancreatic Neuroendocrine Tumors
    Baig, Mirza
    Chin, Un
    Wilhite, Douglas
    Charbel, Halim
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S213 - S213
  • [38] Gastrointestinal and pancreatic neuroendocrine tumors
    Salazar, Ramon
    Villabona, Carlos
    Fabregat, Joan
    MEDICINA CLINICA, 2006, 127 (06): : 227 - 231
  • [39] A case of pancreatic neuroendocrine tumors
    Masato Moriyama
    Yoshifumi Matsumoto
    Qiliang Zhou
    Kanako Yamana
    Yohei Ikeda
    Fumio Ayukawa
    Eisuke Abe
    Seijiro Sato
    Kabuto Takano
    Motoki Kaidu
    Hidefumi Aoyama
    Yasuo Saijo
    International Cancer Conference Journal, 2016, 5 (1) : 1 - 4
  • [40] Management of Pancreatic Neuroendocrine Tumors
    Halperin, Daniel M.
    Kulke, Matthew H.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2012, 41 (01) : 119 - +
12345